Research Articles - Macular Degeneration
In the first-ever clinical trials of a stem cell treatment for retinal disease, two women – one with dry age-related macular degeneration (AMD), the other with Stargardt disease – demonstrated improved vision, including the ability to read more lines on an eye chart with their treated eyes.
Most important, the treatment is improving their independence and ability to perform daily activities. The 78-year-old woman with dry AMD says that she has begun making her own breakfast and shopping by herself. The Stargardt patient,
Widely reported research published last week in the medical journal The Lancet spells good news for the Massachusetts-based Advanced Cell Technology (ACT) and its emerging retinal-disease treatment. Results from two early clinical trials indicate there were no serious adverse events associated with its stem-cell-derived therapy. Also, it appeared to improve vision in some patients with two kinds of macular